KALARIS THERAPEUTICS, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KALARIS THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-06-30 was 0.00 shares.
- KALARIS THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-03-31 was 0.00 shares.
- KALARIS THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-12-31 was 0.00 shares.
- KALARIS THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-09-30 was 0.00 shares.
- KALARIS THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 0.00 shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 0.00 shares 10-K · filed 2026-03-17 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |